Skip to main content

Exicure, Inc.

XCUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001698530

No open-market purchases or sales by Exicure, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $306.0K in total; no superinvestor holds it.

Holders of 5% or more of XCUR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Exicure, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of XCUR
HolderLatest formStakeChangeFirst filedLatest filingFiling
Exicure HiTron Inc.13D/A52.80%3.33M shares0.00 ppfrom 52.80%Mar 26, 20252 filingsSep 22, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Exicure, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on XCUR
Filed (ET)FilerFormStakeChangeEvent dateFiling
Dec 10, 20258:53 PM ETSangsangin Investment & Securities Co., Ltd.and 2 others13G/A0.00%0 shares−14.30 ppfrom 14.30%Below 5%Dec 8, 2025SEC
Sep 22, 20254:37 PM ETExicure HiTron Inc.13D/A52.80%3.33M shares0.00 ppfrom 52.80%Sep 18, 2025SEC
Mar 26, 20255:48 PM ETHiTron Systems Inc.13D/A52.80%3.33M shares–Dec 26, 2024SEC
Dec 23, 20248:46 PM ETSangsangin Investment & Securities Co., Ltd.and 2 others13G14.30%433.3K sharesNewDec 12, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Exicure, Inc. shares.

No Form 144 notices for Exicure, Inc. are on file.